The report titled "Asia Pacific Nutraceuticals Market Outlook 2021 - Extensive Customer Base Coupled with Rising Disposable Income in India and China to Foster Growth" provides a comprehensive analysis of nutraceuticals market in Asia-Pacific region.
The report focuses on overall market size for Asia Pacific nutraceuticals market, market segmentation on the basis of Dietary Supplements, Functional Foods and Beverages, sub-segmentations on the basis of Dietary Supplements by Type of Supplements, Functional Foods and Beverages by Food Category and market segmentation by countries (China, Japan, India, Australia, Korea, Thailand, Vietnam).
The report also covers competitive landscape and market share of major players in nutraceuticals market, countries' import and export scenario, major government regulations and future projections for nutraceuticals market in each country. The report concludes with market projection for future and analyst recommendation highlighting the major opportunities and cautions.
Key Topics Covered:
1. Executive Summary
2. Research Methodology
3. Asia Pacific Nutraceuticals Market
4. China
5. Japan
6. India
7. Australia
8. Korea
9. Thailand
10. Vietnam
11. Company profiles for Nutraceuticals market
12. Future Analysis of Asia Pacific Nutraceuticals Market, 2016-2021
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...